98
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Influence of analgesic active 3-[4-(3-trifluoromethyl-phenyl)-piperazin-1-yl]-dihydrofuran-2-one on the antioxidant status, glucose utilization and lipid accumulation in some in vitro and ex vivo assays

, , , , , , , , , & show all
Pages 204-211 | Received 09 Sep 2013, Accepted 30 Dec 2013, Published online: 17 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Kinga Sałat, Jadwiga Witalis, Monika Zadrożna, Zbigniew Sołtys, Barbara Nowak, Barbara Filipek, Krzysztof Więckowski & Barbara Malawska. (2015) 3-[4-(3-Trifluoromethyl-phenyl)-piperazin-1-yl]-dihydrofuran-2-one and pregabalin attenuate tactile allodynia in the mouse model of chronic constriction injury. Toxicology Mechanisms and Methods 25:7, pages 514-523.
Read now

Articles from other publishers (2)

Daniel Jan Strub, Kinga Sałat, Tadeusz Librowski, Stanisław Lochyński, Magdalena Gaweł & Adrian Podkowa. (2016) The anxiolytic-like activity of a novel N-cycloalkyl-N-benzoylpiperazine derivative. Pharmacological Reports 68:1, pages 62-65.
Crossref
Kinga Sałat, Agnieszka Cios, Elżbieta Wyska, Robert Sałat, Szczepan Mogilski, Barbara Filipek, Krzysztof Więckowski & Barbara Malawska. (2014) Antiallodynic and antihyperalgesic activity of 3-[4-(3-trifluoromethyl-phenyl)-piperazin-1-yl]-dihydrofuran-2-one compared to pregabalin in chemotherapy-induced neuropathic pain in mice. Pharmacology Biochemistry and Behavior 122, pages 173-181.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.